Saakshi Medtech & Panels
Key Fundamentals
SMEElectrical EquipmentCapital GoodsPrice-based figures as of · TTM
- ROCE
- 14.30%
- Debt to Equity
- 0.23
- EPS (TTM)
- —
- Book Value
- ₹77.26
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- 4.85
- ROE
- 11.80%
- Dividend Yield
- 0.00%
- EBITDA
- ₹10.90 Cr
- 52W High
- ₹381.45
- 52W Low
- ₹151.10
- Day Range
- ₹360.00 – ₹374.35
- Volume
- 3,900
Peer Comparison
Industrials › Capital Goods › Other Electrical Equipment
| ₹2,408.00 | 18.15 | ₹67,713 Cr | 4.32 | 0.17% | 32.50% | 38.40% | ₹30,043 Cr | ₹4,003 Cr | |
| ₹15,998.00 | 54.39 | ₹65,476 Cr | 7.86 | 0.39% | 20.30% | 31.80% | ₹24,389 Cr | ₹1,181 Cr | |
| ₹904.00 | 24.61 | ₹40,624 Cr | 9.53 | 0.11% | 41.00% | 32.70% | ₹8,466 Cr | ₹1,674 Cr | |
| ₹385.85 | 111.84 | ₹22,658 Cr | — | 0.00% | — | 10.40% | ₹2,348 Cr | ₹182 Cr | |
| ₹6,036.50 | 137.95 | ₹19,040 Cr | 22.57 | 0.05% | 12.60% | 15.20% | ₹1,080 Cr | ₹134 Cr | |
| ₹246.41 | 12.03 | ₹16,196 Cr | 3.89 | 0.43% | 50.70% | 44.60% | ₹6,023 Cr | ₹1,418 Cr | |
| ₹2,041.00 | 102.05 | ₹13,437 Cr | 18.92 | 0.00% | 16.50% | 19.30% | ₹1,764 Cr | ₹134 Cr | |
| Saakshi Medtech & Panels (this company) | ₹374.35 | — | ₹725 Cr | 4.85 | 0.00% | 11.80% | 14.30% | — | — |
| Median 8 companies | ₹1,472.50 | 54.39 | ₹20,849 Cr | 7.86 | 0.08% | 20.30% | 25.55% | ₹6,023 Cr | ₹1,181 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 84/100
Category scores
- Quality
- 69
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 34
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 64
- Good
- Sales & profit trajectory 9% weight
- Financial Health
- 72
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 82
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 44
- Weak
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
No strengths listed
Weaknesses
4- Stock is trading at 6.03 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 10.6% over last 3 years.
- Company might be capitalizing the interest cost
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 4 | 5 | 10 |
| Oscillators | Bearish | 4 | 5 | 0 |
| Moving Averages | Strong Bullish | 0 | 0 | 10 |
Oscillators
Bearish
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 60.15
- Neutral
- MACD (12,26,9)
- 4.46
- Bearish
- SMA (50)
- 348.99
- Bullish
- SMA (200)
- 261.74
- Bullish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 5Y | +14.09% |
|---|---|
| 3Y | −1.67% |
| 1Y | +26.09% |
Net profit
| 5Y | +43.10% |
|---|---|
| 3Y | 0.00% |
| 1Y | +140.00% |
Operating cash flow
| 5Y | Zero base |
|---|---|
| 3Y | +17.84% |
| 1Y | +500.00% |
Operating margin· change in pp
| 5Y | +8.97 pp |
|---|---|
| 3Y | +1.76 pp |
| 1Y | +8.10 pp |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2020 | ₹61.00 Cr |
|---|---|
| Mar 2021 | ₹60.00 Cr |
| Mar 2022 | ₹92.00 Cr |
| Mar 2023 | ₹122 Cr |
| Mar 2024 | ₹122 Cr |
| Mar 2025 | ₹92.00 Cr |
| Mar 2026 | ₹116 Cr |
Net profit by year
| Mar 2020 | ₹6.00 Cr |
|---|---|
| Mar 2021 | ₹2.00 Cr |
| Mar 2022 | ₹9.00 Cr |
| Mar 2023 | ₹12.00 Cr |
| Mar 2024 | ₹11.00 Cr |
| Mar 2025 | ₹5.00 Cr |
| Mar 2026 | ₹12.00 Cr |
Half-yearly Results
₹ Cr| Particulars | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 69 | 61 | 61 | 44 | 48 | 58 | 57 |
| Expenses | 57 | 52 | 50 | 38 | 44 | 48 | 46 |
| Operating Profit | 12 | 10 | 10 | 6 | 4 | 11 | 12 |
| OPM % | 17% | 16% | 17% | 15% | 8% | 18% | 20% |
| Other Income | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| PBT | 10 | 7 | 8 | 5 | 2 | 9 | 8 |
| Tax % | 26% | 23% | 25% | 28% | 30% | 25% | 28% |
| Net Profit | 7 | 6 | 6 | 3 | 1 | 7 | 6 |
| EPS (₹) | — | 3.14 | 3.4 | 1.95 | 0.71 | 3.76 | 3.21 |
Profit & Loss
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 61 | 60 | 92 | 122 | 122 | 92 | 116 |
| Expenses | 50 | 54 | 76 | 101 | 102 | 82 | 93 |
| Operating Profit | 11 | 6 | 16 | 21 | 20 | 10 | 22 |
| OPM % | 18% | 10% | 17% | 17% | 16% | 11% | 19% |
| Other Income | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Interest | 2 | 1 | 1 | 1 | 2 | 0 | 1 |
| Depreciation | 2 | 2 | 2 | 3 | 4 | 4 | 5 |
| PBT | 8 | 3 | 13 | 17 | 15 | 7 | 17 |
| Tax % | 24% | 33% | 26% | 25% | 24% | 28% | 26% |
| Net Profit | 6 | 2 | 9 | 12 | 11 | 5 | 12 |
| EPS (₹) | — | — | — | — | 6.41 | 2.67 | 6.96 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 18 | 18 | 18 |
| Reserves | 15 | 18 | 27 | 40 | 76 | 80 | 93 |
| Borrowings | 19 | 22 | 16 | 20 | 18 | 18 | 25 |
| Other Liabilities | 11 | 14 | 19 | 31 | 19 | 15 | 21 |
| Total Liabilities | 48 | 56 | 65 | 93 | 131 | 131 | 157 |
| Fixed Assets | 22 | 22 | 26 | 34 | 62 | 60 | 83 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 13 | 10 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 26 | 34 | 39 | 59 | 68 | 58 | 64 |
| Total Assets | 48 | 56 | 65 | 93 | 131 | 131 | 157 |
Cash Flow
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 11 | 0 | 11 | 11 | 8 | 3 | 18 |
| Investing | −6 | −1 | −5 | −11 | −31 | −15 | −25 |
| Financing | −3 | 2 | −7 | 2 | 36 | −1 | 6 |
| Net Cash Flow | 2 | 1 | −1 | 2 | 12 | −12 | −1 |
| Free Cash Flow | 4 | −1 | 5 | 0 | −24 | −12 | −8 |
| CFO/EBITDA | 115 | 28 | 87 | 73 | 64 | 50 | 100 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 62 | 90 | 70 | 69 | 52 | 86 | 83 |
| Inventory Days | 74 | 95 | 81 | 109 | 102 | 129 | 122 |
| Days Payable | 73 | 97 | 83 | 93 | 43 | 50 | 60 |
| Cash Conversion Cycle | 63 | 88 | 67 | 84 | 110 | 165 | 144 |
| Working Capital Days | −5 | 7 | 30 | 36 | 88 | 129 | 94 |
| ROCE % | — | 12% | 32% | 33% | 19% | 6% | 14% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Saakshi Medtech & Panels insights
54 extracted metrics across FY20–FY26.
Documents
- Concall · Dec 2025Transcript PPT
- Concall · Jul 2025PPT
- Concall · Dec 2024Transcript PPT
- Concall · Dec 2023Transcript PPT
- 3 Oct 2026
- 30 Sep 2026
- 26 Sep 2026
- 15 Sep 2026
- 12 Sep 2026
Frequently Asked Questions about Saakshi Medtech & Panels
What does Saakshi Medtech & Panels Ltd do?
Where is Saakshi Medtech & Panels Ltd (SAAKSHI) listed?
Which sector does Saakshi Medtech & Panels Ltd belong to?
What is the 52-week high and low of Saakshi Medtech & Panels Ltd?
What is the Return on Equity (ROE) of Saakshi Medtech & Panels Ltd?
Company Information
Incorporated in 2009, Saakshi Medtech & Panels Ltd deals in Electrical Control Panels, Medical X-Ray Systems, Fabrication & Wire Harness
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SAAKSHI.md for Saakshi Medtech & Panels Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.